Katedra Kardiologii KAAFM w Bielsku Białej, Centrum Kardiologii i Kardiochirurgii PAKS
- Address
- Armii Krajowej 101, 43-316 Bielsko-Biala, Poland
Katedra Kardiologii KAAFM w Bielsku Białej, Centrum Kardiologii i Kardiochirurgii PAKS
The Department of Cardiology at KAAFM in Bielsko-Biała and the PAKS Cardiology and Cardiac Surgery Center represent a specialized cardiovascular research institution focused on advancing treatment strategies for complex cardiac conditions. The center demonstrates particular expertise in managing patients with multiple concurrent cardiovascular pathologies requiring sophisticated antithrombotic management.
- Acute coronary syndrome management and percutaneous coronary intervention
- Non-valvular atrial fibrillation treatment strategies
- Advanced antithrombotic therapy optimization and bleeding risk reduction
The center is actively engaged in cutting-edge research comparing dual antithrombotic therapy regimens versus traditional triple therapy approaches in high-risk patient populations. Their clinical investigations focus on balancing ischemic protection with bleeding risk reduction in patients with atrial fibrillation who undergo percutaneous coronary intervention following acute coronary syndrome, representing one of the most challenging scenarios in interventional cardiology.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Katedra Kardiologii KAAFM w Bielsku Białej, Centrum Kardiologii i Kardiochirurgii PAKS
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Dual Antithrombotic Therapy with Dabigatran and Ticagrelor in Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing PCI | Medical University Of Gdansk | Phase III | Not Recruiting | Jul 2021 | Oct 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ticagrelor | 1 | Unknown | 2021-07-31 | 2021-07-31 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.